Humans use massage for stress relief and relaxation. Tight wraps can be used on dogs to reduce anxiety from separation, and the swinging cow brush is designed to improve cow health, comfort and welfare.
Read More
0 Comments Click here to read/write comments
Tags: 2014, Duke University, BioResearch Product Faire Event, Durham, NC, Duke
Duke University recently received $10 million in science research funding from the National Institutes of Health to create an Antibacterial Resistance Leadership Group to conduct research lab investigations into the causes of antibacterial resistance. The new research grant was awarded in fiscal year 2014 to the department of internal medicine at Duke University Schools of Medicine and project leader Dr. Vance Fowler.
0 Comments Click here to read/write comments
Tags: 2014, Duke University, North Carolina, new research funding, Southern, BioResearch Product Faire Event, Durham, NC, Duke, new research grant
Are you looking for top funded lab sales marketplace? Duke University is a multi-million dollar player in the multi-billion dollar life science research marketplace. With $350 million NIH funding in 2013, and $45 million in NSF funding, plus private support from foundations and individuals, this is a large and growing market for lab supply companies looking to expand their reach. Duke’s funding compares favorably to that of Harvard University, which had $352 million from NIH funding and $55 million NSF funding respectively.
2 Comments Click here to read/write comments
Tags: 2014, Duke University, Southern, BioResearch Product Faire Event, Durham, NC, Duke
A new Eye Center Clinical Facility at Duke University is currently under construction. The new facility at Duke will house expanded clinical services designed to improve patient care and convenience. The 127,000 square-foot building is expected to be complete in mid 2015 and was made possible by a $12 million donation.
0 Comments Click here to read/write comments
Tags: 2014, Duke University, North Carolina, new research funding, BioResearch Product Faire Event, Durham, NC, new facility
“Despite the clinical success of antiretroviral therapy (ART), more people contract human immunodeficiency virus (HIV) infection daily than initiate ART,” states the NIH RePORTER abstract for a new study receiving funding from the NIH. “The difficulties of lifelong ART - particularly in the developing world - make the eradication of HIV imperative. But clearance of a retroviral infection for patients on ART is a herculean task. While much is known about HIV persistence despite ART, many puzzles remain. New tools to address latent infection must replace the paradigms and models used to develop ART.”
0 Comments Click here to read/write comments
Tags: 2014, University of North Carolina, Southern, Front Line event, NC, Chapel Hill, NIH funding, NIH grant, NIH award, UNC, NC State
The Duke Translational Medicine Institute at Duke University was recently awarded a five-year grant worth over $47 million by the NIH. The life science funding will go towards bringing biomedical research advances to patients. According to the Duke University news page, the Duke Translational Medicine Institute is Duke’s academic base for its clinical and translational research community where training in clinical and translational research is provided.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Duke University, Southern, BioResearch Product Faire Event, Durham, NC, Duke, NIH funding, NIH grant, NIH award
A laboratory testing kit developed at the University of North Carolina Lineberger Comprehensive Cancer Center received approval from the U.S. Food and Drug Administration. Developed by Chuck Perou, PhD and professor of genetics and pathology, the testing kit estimates the risk of breast cancer relapse even in cases of anti-hormone treatment. According to the University of North Carolina at Chapel Hill, other scientists who worked with Perou include Dr. Joel Parker and Dr. Maggie Cheang at the University of North Carolina.
0 Comments Click here to read/write comments
Tags: 2013, breast cancer research, University of North Carolina, Life Science Funding, Southern, BioResearch Product Faire Front Line Event, NC, Chapel Hill, UNC, breast cancer funding
Four start-up medical companies at the University of North Carolina at Chapel Hill recently received $80,000 in life science funding the form of a federal grant. The donating organization, Carolina KickStart, is a program within the North Carolina Translational and Clinical Sciences Institute (NC TraCS). NC TraCS is funded by the NIH and works as a medical research center that awards grant money.
0 Comments Click here to read/write comments
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, BioResearch Product Faire Event, NC, Front Line, Chapel Hill, UNC, life science research funding
Researchers at the University of North Carolina at Chapel Hill recently made an important contribution to life science research with a study published in the September 13th, 2013 issue of the journal Science. Scientists have known for some time that there are sensors on the outside of cells that act as motion detectors for bacteria that may be dangerous. The researchers at the University of North Carolina at Chapel Hill found a sensor pathway inside of cells that that triggers a response by the immune system. According to the study, the interior sensors can work with the exterior sensors to detect a molecule called lipopolysaccharide, or LPS.
0 Comments Click here to read/write comments
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, life science research, BioResearch Product Faire Event, NC, Chapel Hill, UNC, new study, new research
Researchers at Duke University recently made a groundbreaking contribution to the life sciences research field: The Duke researchers found that using certain bone grafting material for spinal fusion only sometimes increases the risk for benign tumors, and it does not increase the risk for cancer. Benign tumors were more common in patients who received the bone promoter recombinant human bone morphogenetic protein 2, also known as BMP.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Duke University, cancer research, Southern, BioResearch Product Faire Event, Durham, NC, Duke, research news